This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Astrazeneca Ab. Active years: 2012-2013.
Location History:
- Macclesfield, GB (2012)
- Cheshire, GB (2013)
Company Filing History:
Years Active: 2012-2013
Title: Simon Nicholas Black: Innovator in Pharmaceutical Patents
Introduction
Simon Nicholas Black is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 2 patents. His work focuses on innovative formulations and compositions that have potential applications in medicine.
Latest Patents
Among his latest patents, Simon has developed crystalline forms of 11-piperazin-1-yldibenzo[b,f][1,4]thiazepine, along with its compositions, preparations, formulations, prodrugs, and pharmaceutical uses. Additionally, he has worked on polymorphs of N,N-diethyl-4-(3-fluorophenyl-piperidin-4-ylidene-methyl)-benzamide hydrochloride salt, detailing methods of making these polymorphs and their uses.
Career Highlights
Simon is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His role involves research and development in the pharmaceutical sector, where he applies his expertise to create innovative solutions for healthcare challenges.
Collaborations
Some of his notable coworkers include James Hulsizer and Greg Christoph, who contribute to the collaborative environment at AstraZeneca AB.
Conclusion
Simon Nicholas Black's contributions to pharmaceutical innovations through his patents highlight his role as a key inventor in the industry. His work continues to influence the development of new medical therapies.